BAXTER INTL INC (NYSE: BAX)

Sector: Medical

Current Price : $72.30

52 Week Low
$49.0352 Week High
$72.64

Press Releases
Baxter to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
Strategy Behind Our Success, We Get in Early: PSX, AMGN, MPC and BAX
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease
Baxter Raises Dividend Nine Percent
Vaxfectin(R) Enhances Preclinical Immune Responses to Baxter's Cell Culture-Derived Influenza Vaccines
Baxter to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Baxter to Webcast Annual Meeting of Shareholders
Free Research Reports on AAMRQ, ACI, BAX and PTGI Issued by the Paragon Report
Baxter Achieves Its First Quarter Expectations and Confirms 2013 Full-Year Guidance
Baxter Marks World Hemophilia Day by Reinforcing Commitment to Addressing Disparities in Care and Sharing New Vision for the Future
Baxter Taps New Technologies, Forms Collaborations to Improve Environmental Sustainability and Access to Healthcare
Baxter International First Quarter 2013 Financial Results Conference Call
StockCall Scrutinizes Baxter Intl., CareFusion, Nanosphere, and Mindray Medical Intl.
Baxter and Halozyme Announce Positive Opinion for HyQvia for Treatment of Primary and Secondary Immunodeficiencies in the European Union
Potential Buyouts, Stronger Pipelines, FDA Filings - Research Report on Keryx, Lilly, Baxter, Biogen Idec and Shire
The Real Story Behind CLR, TJX, BAX and LKQ
Baxter to Present at Raymond James 34th Annual Institutional Investors Conference
Baxter Submits Application for FDA Approval of FEIBA NF for Prophylactic Use in Hemophilia A and B Patients with Inhibitors
Technical Research on CareFusion and Baxter: Medical Equipment Companies on M&A Spree
Baxter Declares Quarterly Dividend
Free Research Report on C.H. Robinson Worldwide, Inc., Gannett Co., Inc., Transocean, Inc., Baxter International, Inc. and Universal Display Corp.
Should Recent Insider Selling on BAX, URI, ALGN and DLB Matter to You?
Baxter to Present at Upcoming Global Healthcare Conferences
The Real Story Behind BAX, WMB, HOG and NEE
Baxter Announces Agreement to Acquire Investigational Hemophilia Compound OBI-1 and Related Assets
Baxter Reports Record Sales, Earnings and Cash Flow for Full-Year 2012
Is Atrion Corp Set to Continue its Rebound?
St. Joseph's/Candler Health System in Savannah, Ga. Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
Baxter International Fourth Quarter 2012 Financial Results Conference Call
Baxter to Present at 31st Annual J.P. Morgan Healthcare Conference
Baxter to Present at 31st Annual J.P. Morgan Healthcare Conference
Baxter Enhances Renal Therapies Portfolio with Acquisition of Gambro
Baxter Declares Quarterly Dividend
Baxter to Present at the 24th Annual Piper Jaffray Healthcare Conference
Financial Review on Healthcare Stocks Baxter Intl. Inc. and Thermo Fisher Scientific Inc. - Medical Instrument Makers Looking to Grow
Baxter's Commitment to Incorporating Sustainable Practices into Business Recognized by Leading Organizations
Baxter to Present at Credit Suisse 21st Annual Healthcare Conference
NuPathe Announces Closing of $28 Million Private Placement and Changes to Its Board of Directors
Traders Look to New Levels Ahead - Research & Analysis on Baxter International Inc. and Capital One Financial Corporation
Baxter Hosts 2012 Investor Conference
Baxter Appoints Two New Directors to Its Board
Baxter International Third Quarter 2012 Financial Results Conference Call
Baxter Hosting Investor Conference on October 9, 2012
Baxter and Onconova Announce European Licensing Agreement for Anti-Cancer Compound Rigosertib
Baxter Hosting Investor Conference on October 9, 2012
Baxter to Present at Morgan Stanley Global Healthcare Conference
Baxter Confirms Receipt of Complete Response Letter on HyQ
Baxter Raises Dividend 34 Percent and Announces New $2 Billion Share Repurchase Program
Baxter Announces Collaboration with Sanquin to Expand Capacity for Plasma Therapies
Baxter Announces FDA Approval of ADVATE 4000 IU Dosage Strength
Baxter's 2011 Sustainability Report Focuses on Creating Lasting Value for Stakeholders
Baxter International Second Quarter 2012 Financial Results Conference Call
Where Opportunity Is Found - Research & Analysis on ConocoPhillips and Baxter International Inc.
Calendar of Events - Report Highlights Baxter International Inc. and HCA Holdings Inc
Equities Lead Investor Sentiment - Research Report on Baxter International Inc. and HCA Holdings Inc
Equity Research on Baxter International Inc. and Thermo Fisher Scientific Inc. - Medical Instruments & Supplies Companies Expanding Abroad in Wake of Domestic Headwinds
Baxter to Present at William Blair & Company 32nd Annual Growth Stock Conference
Baxter's Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing Dialysis
Baxter to Present at Goldman Sachs 33rd Annual Global Healthcare Conference
Baxter Declares Quarterly Dividend
Baxter to Present at Bank of America Merrill Lynch 2012 Healthcare Conference
Baxter Completes Purchase of Sigma International
Baxter to Present at Deutsche Bank Securities, Inc. 37th Annual Healthcare Conference
Baxter to Webcast Annual Meeting of Shareholders
Baxter Exceeds Revenue and EPS Guidance with Solid First Quarter Financial Results
Baxter Announces Biologics Capacity Expansion to Support Global Growth in Plasma-Derived Therapies
Baxter International First Quarter 2012 Financial Results Conference Call
Baxter and Its Foundation Aid Local Communities Through 2011 Charitable Giving
Baxter Presents Long-Term Data on HyQ During AAAAI Annual Meeting
Baxter Receives Marketing Authorization in European Union for VEPACEL Pre-Pandemic Influenza Vaccine
Baxter to Present at the Barclays Capital 2012 Global Healthcare Conference
Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition
A Forward Look, the Year Ahead - Featured Research on Baxter International Inc. and Teleflex Incorporated
Baxter Declares Quarterly Dividend
Baxter to Present at the Cowen and Company 32nd Annual Healthcare Conference
Baxter to Present at the Citi 2012 Global Healthcare Conference
Baxter Completes Acquisition of Synovis
Baxter to Present at the RBC Capital Markets Healthcare Conference
Baxter to Host Investor Conference on October 9, 2012
Baxter Announces FDA Approval of Expanded Indication for TISSEEL [Fibrin Sealant] for General Hemostasis in Surgery
Baxter and Momenta Announce Collaboration to Develop and Commercialize Follow-On Biologics
Baxter to Present at the 30th Annual J.P. Morgan Health Care Conference
FDA Approves Baxter's ADVATE as the Only FVIII for Routine Prophylaxis in Both Adults and Children With Hemophilia A
The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Synovis Life Technologies Inc. in Connection With the Sale of the Company to Baxter International Inc.
Baxter Responds to Patient Needs in Aftermath of Thailand Floods
The Law Firm of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches of Fiduciary Duty by the Board of Synovis Life Technologies Inc. in Connection With the Sale of the Company to Baxter International Inc.
Baxter Signs Definitive Agreement to Acquire Synovis
Equity Research on Baxter International Inc. and Thermo Fisher Scientific Inc. - Acquisitions and R&D Driving Medical Instruments and Supplies
Baxter to Present at the 23rd Annual Piper Jaffray Health Care Conference
S&P Capital IQ Publishes Quality Trends, An In-Depth Analysis of "Quality" in the Equity Markets
Baxter Corporation and Medbuy First Trading Partners in Canada to Synchronize Medical-Surgical Product Data
Baxter Presents Phase III HyQ Efficacy and Tolerability Data at American College of Allergy, Asthma & Immunology Meeting
Baxter Introduces NUMETA in Europe as the First-Ever Triple-Chamber IV Nutrition System for Preterm Newborns and Children
Statement on Prophylaxis with FEIBA - Study Results Published Today in The New England Journal of Medicine
Baxter to Present at the Credit Suisse 2011 Healthcare Conference
Ligand to Report Third Quarter Results on November 8
Baxter Initiates Phase III Trial of Investigational BAX 111 For the Treatment of von Willebrand Disease
Honor Society of Nursing Recognizes Researcher for Significant Contributions to Evidence-Based Practice Research
Baxter Advances Initiative Supporting Math and Science Education
Leading Nutrition Experts Convene First-Ever Summit to Address Parenteral Nutrition Safety

iStock Rating

BAXTER INTL INC (NYSE: BAX)

Sector: Medical

Company

Community

Analysis

Charts

Analyst

Ratios